AI assistant
Take Solutions Ltd — M&A Activity 2019
Mar 5, 2019
60381_rns_2019-03-05_d8c6c71f-e713-470f-a4a1-446f9bb923c0.pdf
M&A Activity
Open in viewerOpens in your device viewer

TECHNOLOGY ANALYTICS KNOWLEDGE ENTERPRISE
March 1, 2019
TAKE/BSE/2018-19
The Manager Dept. of Corporate Services-Listing Bombay Stock Exchange Limited, P. J. Towers, Dalal Street, Mumbai - 400001 Scrip Code: 532890
TAKE/NSE/2018-19
The Manager-Listing Department National Stock Exchange of India Limited Exchange Plaza, Bandra - Kurla Complex, Bandra (East), Mumbai - 400051 Symbol: TAKE
Sir/ Madam,
Sub: Intimation regarding Merger of Subsidiaries.
With reference to the captioned subject, please take note of the following mergers of Step-Down Subsidiaries of the Company in USA:
Transaction 1
Merger of:
- a) Astus Technolgies Inc, USA
- b) TAKE Dataworks Inc, USA
- c) TAKE Synergies Inc, USA
into its holding Company, namely TAKE Innovations Inc, USA (a step-down subsidiary of TAKE Solutions Ltd) w.e.f. February 22, 2019.
Transaction 2
·
Merger of Navitas Life Sciences Inc, USA with Navitas Inc, USA, both are direct subsidiaries of Navitas Lifesciences Holdings Ltd, UK (a (a step down subsidiary of TAKE Solutions Ltd) w.e.f. February 25, 2019.
Details in terms of SEBI (Listing and Disclosure Obligation Requirements) Regulations, 2015, read with SEBI circular No. CIR/CFD/CMD/4/2015 dated 9 th September 2015, are attached herewith as Annexure - I, II, Ill and IV of this intimation.

,, TAKE SOLUTIONS LIMITED
. , Registered & Corporate Office : No: 27, Tank Bund Road, Nungambakkam, (henna, - 600 034 • . � • CIN: L63090TN2000PLC046338; GSTIN: 33AABCT3684M1 Z0 • Tel: +91 44 6611 0700/01

We request you to take note of the aforesaid and acknowledge receipt.
Company Secretary

Encl: As Above

Annexure-1
Transaction - 1 (a)
| S.No | Particulars | Details of entities forming part ofmerger |
|---|---|---|
| a) | Details in brief such as size, turnover etc | Name of the entity: Astus TechnologiesInc, USA merging into TAKE InnovationsInc, USA |
| Turnover as on March 31, 2018 | USD 45.54 mn | |
| b) | Whether the merger would fall withinrelated party transaction(s) and whetherthe promoter/ promoter group/ groupcompanies have any interest in the entitybeing acquired? | Not a Related Party Transaction |
| c) | Area of Business of the entities | Life Sciences |
| d) | Rationale for amalgamation/ merger | The merger enables a lighter and morerationalized organization structure andresults in fewer administrative andcompliance costs. |
| e) | In case of Cash consideration -amountor otherwise share exchange ration | None, as the Wholly Owned Subsidiarycompany has been merged with itsParent Company |
| f) | Brief details of change in shareholdingpattern (if any) of Listed Entity | None |

Annexure - II
Transaction -1 (b)
| S.No | Particulars | Details of entities forming part ofmerger |
|---|---|---|
| a) | Details in brief such as size, turnover etc | Name of the entity: TAKE DataworksInc, USA merging into TAKE InnovationsInc, USA |
| Turnover as on March 31, 2018 | USD 39.14 | |
| b) | Whether the merger would fall withinrelated party transaction(s) and whetherthe promoter/ promoter group/ groupcompanies have any interest in the entitybeing acquired? | Not a Related Party Transaction |
| c) | Area of Business of the entities | Life Sciences |
| d) | Rationale for amalgamation/ merger | The merger enables a lighter and morerationalized organization structure andresults in fewer administrative andcompliance costs. |
| e) | In case of Cash consideration -amount orotherwise share exchange ration | None, as the Wholly Owned Subsidiarycompany has been merged with itsParent Company |
| f) | Brief details of change in shareholdingpattern (if any) of Listed Entity | None |


Annexure - Ill
Transaction -1 (c)
| S.No | Particulars | Details of entities forming part ofmerger |
|---|---|---|
| a) | Details in brief such as size, turnover etc | Name of the entity: TAKE Synergies Inc,USA merging into TAKE Innovations Inc,USA |
| Turnover as on March 31, 2018 | USD 40.77 | |
| b) | Whether the merger would fall withinrelated party transaction(s) and whetherthe promoter/ promoter group/ groupcompanies have any interest in the entitybeing acquired? | Not a Related Party Transaction |
| c) | Area of Business of the entities | Life Sciences |
| d) | Rationale for amalgamation/ merger | The merger enables a lighter and morerationalized organization structure andresults in fewer administrative andcompliance costs. |
| e) | In case of Cash consideration -amount orotherwise share exchange ration | None, as the Wholly Owned Subsidiarycompany has been merged with itsParent Company |
| f) | Brief details of change in shareholdingpattern {if any) of Listed Entity | None |


Annexure - IV
Transaction 2
| S.No | Particulars | Details of entity forming part ofmerger |
|---|---|---|
| a) | Details in brief such as size, turnover etc | Nameoftheentity:NavitasLifeSciences Inc merging into Navitas Inc,USA |
| Turnover as on March 31, 2018 | USO 4.21 mn | |
| b) | Whether the merger would fall withinrelated party transaction(s) and whetherthe promoter/ promoter group/ groupcompanies have any interest in the entitybeing acquired? | Not a Related Party Transaction |
| c) | Area of Business of the entities | Life Sciences |
| d) | Rationale for amalgamation/ merger | The merger enables a lighter and morerationalized organization structure andresults in fewer administrative costs. |
| e) | In case of Cash consideration -amount orotherwise share exchange ration | None, as both the merged entities aresubsidiary of same parent Company |
| f) | Brief details of change in shareholdingpattern (if any) of Listed Entity | None |
